Brokerages Set Walgreens Boots Alliance, Inc. (NASDAQ:WBA) Target Price at $12.88

Shares of Walgreens Boots Alliance, Inc. (NASDAQ:WBA - Get Free Report) have been assigned a consensus rating of "Reduce" from the fifteen analysts that are presently covering the company, Marketbeat reports. Four analysts have rated the stock with a sell rating, nine have given a hold rating and two have issued a buy rating on the company. The average 1 year price objective among analysts that have issued a report on the stock in the last year is $12.88.

A number of research analysts recently commented on WBA shares. JPMorgan Chase & Co. lowered their price target on Walgreens Boots Alliance from $20.00 to $15.00 and set an "overweight" rating on the stock in a report on Friday, August 30th. Barclays raised their price target on Walgreens Boots Alliance from $7.00 to $8.00 and gave the company an "underweight" rating in a report on Wednesday, October 16th. Evercore ISI upped their price objective on Walgreens Boots Alliance from $7.50 to $10.00 and gave the stock an "in-line" rating in a report on Wednesday, October 16th. Jefferies Financial Group cut their target price on shares of Walgreens Boots Alliance from $19.00 to $9.00 and set a "hold" rating for the company in a report on Wednesday, October 23rd. Finally, Morgan Stanley reduced their price target on shares of Walgreens Boots Alliance from $9.00 to $7.00 and set an "underweight" rating on the stock in a research report on Friday, October 11th.

Walgreens Boots Alliance Stock Up 0.4 %

NASDAQ:WBA traded up $0.04 during mid-day trading on Thursday, hitting $9.27. 19,160,336 shares of the company's stock were exchanged, compared to its average volume of 17,289,021. Walgreens Boots Alliance has a one year low of $8.22 and a one year high of $27.05. The business has a fifty day moving average price of $9.18 and a 200 day moving average price of $12.30. The company has a market cap of $8.01 billion, a PE ratio of -0.93, a P/E/G ratio of 1.22 and a beta of 0.69. The company has a debt-to-equity ratio of 0.67, a current ratio of 0.68 and a quick ratio of 0.37.

Walgreens Boots Alliance (NASDAQ:WBA - Get Free Report) last posted its quarterly earnings results on Tuesday, October 15th. The pharmacy operator reported $0.39 earnings per share for the quarter, topping the consensus estimate of $0.36 by $0.03. The company had revenue of $37.50 billion for the quarter, compared to the consensus estimate of $35.75 billion. Walgreens Boots Alliance had a positive return on equity of 14.23% and a negative net margin of 5.85%. The firm's quarterly revenue was up 5.9% compared to the same quarter last year. During the same quarter in the prior year, the business posted $0.67 EPS. Equities analysts predict that Walgreens Boots Alliance will post 1.53 EPS for the current year.

Walgreens Boots Alliance Dividend Announcement

The firm also recently declared a quarterly dividend, which will be paid on Thursday, December 12th. Stockholders of record on Monday, November 18th will be given a $0.25 dividend. The ex-dividend date of this dividend is Monday, November 18th. This represents a $1.00 annualized dividend and a dividend yield of 10.79%. Walgreens Boots Alliance's payout ratio is presently -9.99%.

Institutional Trading of Walgreens Boots Alliance

Hedge funds and other institutional investors have recently bought and sold shares of the stock. Iron Horse Wealth Management LLC increased its position in shares of Walgreens Boots Alliance by 162.5% during the second quarter. Iron Horse Wealth Management LLC now owns 2,100 shares of the pharmacy operator's stock worth $25,000 after purchasing an additional 1,300 shares in the last quarter. Blue Trust Inc. raised its holdings in shares of Walgreens Boots Alliance by 87.0% during the second quarter. Blue Trust Inc. now owns 2,324 shares of the pharmacy operator's stock worth $28,000 after purchasing an additional 1,081 shares during the last quarter. Continuum Advisory LLC boosted its stake in shares of Walgreens Boots Alliance by 71.2% in the second quarter. Continuum Advisory LLC now owns 2,453 shares of the pharmacy operator's stock worth $30,000 after buying an additional 1,020 shares during the last quarter. Sentry Investment Management LLC purchased a new stake in Walgreens Boots Alliance in the 3rd quarter worth approximately $30,000. Finally, Eastern Bank acquired a new stake in shares of Walgreens Boots Alliance during the 3rd quarter worth approximately $33,000. Institutional investors own 58.59% of the company's stock.

Walgreens Boots Alliance Company Profile

Walgreens Boots Alliance, Inc operates as a healthcare, pharmacy, and retail company in the United States, the United Kingdom, Germany, and internationally. It operates through three segments: U.S. Retail Pharmacy, International, and U.S. Healthcare. The U.S. Retail Pharmacy segment engages in operation of the retail drugstores, health and wellness services, specialty, and home delivery pharmacy services, which offers health and wellness, beauty, personal care and consumables, and general merchandise.